Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8889997rdf:typepubmed:Citationlld:pubmed
pubmed-article:8889997lifeskim:mentionsumls-concept:C0016085lld:lifeskim
pubmed-article:8889997lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:8889997lifeskim:mentionsumls-concept:C0023968lld:lifeskim
pubmed-article:8889997lifeskim:mentionsumls-concept:C0023924lld:lifeskim
pubmed-article:8889997lifeskim:mentionsumls-concept:C0022877lld:lifeskim
pubmed-article:8889997lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:8889997lifeskim:mentionsumls-concept:C2348519lld:lifeskim
pubmed-article:8889997pubmed:issue2lld:pubmed
pubmed-article:8889997pubmed:dateCreated1997-1-30lld:pubmed
pubmed-article:8889997pubmed:abstractTextTo assess differences between Africans and expatriates, we reviewed records of 100 patients with loiasis presenting to The Hospital for Tropical Diseases, London. Fifty-one were black Africans, and 49 were white expatriates. A history of Calabar swellings was more common amongst expatriates (P = 0.0001, OR 8.1), whilst eyeworm was reported more frequently in Africans (P = 0.0038, OR 4.2). Higher eosinophil levels (P < 0.0001) and filarial antibody levels, whether measured by immunofluorescence (P = 0.047) or ELISA (P < 0.0001) were present in the expatriates. Africans were more likely to have microfilaraemia (P < 0.0025, OR 7.3), and among microfilaraemic patients, Africans had denser microfilaraemia (P = 0.012). The sensitivity of microfilaremia as a screening test for loiasis was 75% in Africans and 29% in expatriates. The sensitivities of filarial antibody tests in Africans and expatriates were 81% and 100% for IFAT, and 28% and 93% for ELISA. Following treatment, 63% of patients were considered cured, 25% were lost to follow-up and 12% had a documented relapse. The differences between the two groups of patients could be caused by differences in the chronicity of loiasis, but other explanations are also discussed.lld:pubmed
pubmed-article:8889997pubmed:languageenglld:pubmed
pubmed-article:8889997pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8889997pubmed:citationSubsetIMlld:pubmed
pubmed-article:8889997pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8889997pubmed:statusMEDLINElld:pubmed
pubmed-article:8889997pubmed:monthSeplld:pubmed
pubmed-article:8889997pubmed:issn0163-4453lld:pubmed
pubmed-article:8889997pubmed:authorpubmed-author:WrightS GSGlld:pubmed
pubmed-article:8889997pubmed:authorpubmed-author:MorrisCClld:pubmed
pubmed-article:8889997pubmed:authorpubmed-author:DavidsonR NRNlld:pubmed
pubmed-article:8889997pubmed:authorpubmed-author:ChurchillD...lld:pubmed
pubmed-article:8889997pubmed:authorpubmed-author:FakoyaAAlld:pubmed
pubmed-article:8889997pubmed:issnTypePrintlld:pubmed
pubmed-article:8889997pubmed:volume33lld:pubmed
pubmed-article:8889997pubmed:ownerNLMlld:pubmed
pubmed-article:8889997pubmed:authorsCompleteYlld:pubmed
pubmed-article:8889997pubmed:pagination103-9lld:pubmed
pubmed-article:8889997pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:meshHeadingpubmed-meshheading:8889997-...lld:pubmed
pubmed-article:8889997pubmed:year1996lld:pubmed
pubmed-article:8889997pubmed:articleTitleClinical and laboratory features of patients with loiasis (Loa loa filariasis) in the U.K.lld:pubmed
pubmed-article:8889997pubmed:affiliationHospital for Tropical Diseases, London, U.K.lld:pubmed
pubmed-article:8889997pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8889997lld:pubmed